ARMISTICE CAPITAL, LLC - Q4 2020 holdings

$2.94 Billion is the total value of ARMISTICE CAPITAL, LLC's 106 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 64.4% .

 Value Shares↓ Weighting
SPY  SPDR S&P 500 ETF TRput$411,268,000
+11.6%
11,0000.0%13.99%
+4.7%
IWM SellISHARES TRput$294,090,000
+22.7%
15,000
-6.2%
10.00%
+15.0%
CERC BuyCERECOR INC$79,555,000
+16.5%
30,134,285
+0.4%
2.71%
+9.2%
SUPN SellSUPERNUS PHARMACEUTICALS INC$78,499,000
+17.7%
3,120,000
-2.5%
2.67%
+10.4%
VNDA SellVANDA PHARMACEUTICALS INC$70,946,000
+34.8%
5,399,277
-0.9%
2.41%
+26.3%
LNTH BuyLANTHEUS HLDGS INC$70,148,000
+14.5%
5,200,000
+7.5%
2.39%
+7.3%
BMY BuyBRISTOL-MYERS SQUIBB CO$64,263,000
+6.6%
1,036,000
+3.6%
2.19%
-0.0%
REGN BuyREGENERON PHARMACEUTICALS$63,771,000
+35.6%
132,000
+57.1%
2.17%
+27.1%
BIIB BuyBIOGEN INC$63,174,000
+122.7%
258,000
+158.0%
2.15%
+108.8%
MRTX BuyMIRATI THERAPEUTICS INC$59,742,000
+114.2%
272,000
+61.9%
2.03%
+100.8%
INCY BuyINCYTE CORP$58,972,000
+3.3%
678,000
+6.6%
2.01%
-3.1%
ENTA BuyENANTA PHARMACEUTICALS INC$57,088,000
+138.0%
1,356,000
+158.8%
1.94%
+123.2%
WMT NewWALMART INC$53,368,000370,225
+100.0%
1.82%
BHVN SellBIOHAVEN PHARMACTL HLDG CO L$49,026,000
-16.2%
572,000
-36.4%
1.67%
-21.4%
FIVE BuyFIVE BELOW INC$46,927,000
+197.5%
268,185
+115.9%
1.60%
+179.0%
ALKS BuyALKERMES PLC$44,209,000
+25.6%
2,216,000
+4.3%
1.50%
+17.8%
PTCT SellPTC THERAPEUTICS INC$43,697,000
+29.1%
716,000
-1.1%
1.49%
+21.0%
ENR SellENERGIZER HLDGS INC NEW$41,252,000
-37.2%
978,000
-41.7%
1.40%
-41.1%
ORLY NewOREILLY AUTOMOTIVE INC$40,995,00090,583
+100.0%
1.39%
ULTA NewULTA BEAUTY INC$39,715,000138,304
+100.0%
1.35%
CENTA BuyCENTRAL GARDEN & PET COcl a non-vtg$38,655,000
+10.0%
1,064,000
+9.5%
1.32%
+3.2%
BLUE BuyBLUEBIRD BIO INC$37,991,000
-12.0%
878,000
+9.8%
1.29%
-17.5%
CPB SellCAMPBELL SOUP CO$37,133,000
-16.2%
768,000
-16.2%
1.26%
-21.4%
MDGL BuyMADRIGAL PHARMACEUTICALS INC$35,130,000
+6.4%
316,000
+13.7%
1.20%
-0.2%
UNH SellUNITEDHEALTH GROUP INC$35,068,000
-25.0%
100,000
-33.3%
1.19%
-29.7%
CPRX  CATALYST PHARMACEUTICALS INC$33,400,000
+12.5%
10,000,0000.0%1.14%
+5.5%
FTDR SellFRONTDOOR INC$32,938,000
-2.9%
656,000
-24.8%
1.12%
-9.0%
KO SellCOCA COLA CO$32,904,000
+2.9%
600,000
-7.4%
1.12%
-3.6%
SPPI BuySPECTRUM PHARMACEUTICALS INC$32,709,000
+5.9%
9,592,000
+26.7%
1.11%
-0.8%
AZO SellAUTOZONE INC$32,705,000
-45.9%
27,589
-46.2%
1.11%
-49.2%
TGT NewTARGET ORD$31,544,000178,687
+100.0%
1.07%
NUVA BuyNUVASIVE INC$30,418,000
+39.2%
540,000
+20.0%
1.04%
+30.5%
MDT SellMEDTRONIC PLC$29,988,000
-32.6%
256,000
-40.2%
1.02%
-36.8%
BGS NewB & G FOODS INC NEW$29,505,0001,064,000
+100.0%
1.00%
ROST SellROSS STORES INC$26,071,000
-36.5%
212,284
-51.8%
0.89%
-40.5%
BURL NewBURLINGTON STORES INC$25,486,00097,443
+100.0%
0.87%
VYGR BuyVOYAGER THERAPEUTICS INC$24,253,000
-15.8%
3,392,000
+25.6%
0.82%
-21.1%
BABA NewALIBABA GROUP HLDG LTDsponsored ads$24,204,000104,000
+100.0%
0.82%
DXCM NewDEXCOM INC$23,662,00064,000
+100.0%
0.80%
ARGX SellARGENX SEsponsored adr$23,527,000
+5.4%
80,000
-5.9%
0.80%
-1.1%
TWNK SellHOSTESS BRANDS INCcl a$23,102,000
-11.8%
1,578,000
-25.7%
0.79%
-17.3%
MDLZ SellMONDELEZ INTL INCcl a$22,920,000
+0.7%
392,000
-1.0%
0.78%
-5.5%
ZYME SellZYMEWORKS INC$21,267,000
-36.2%
450,000
-37.2%
0.72%
-40.2%
BCOR SellBLUCORA INC$21,128,000
-25.2%
1,328,000
-55.7%
0.72%
-29.9%
BNTX SellBIONTECH SEsponsored ads$19,239,000
-17.3%
236,000
-29.8%
0.65%
-22.5%
BIO BuyBIO RAD LABS INCcl a$19,237,000
+86.6%
33,000
+65.0%
0.65%
+74.9%
DKS SellDICKS SPORTING GOODS INC$18,684,000
-23.1%
332,389
-20.9%
0.64%
-28.0%
ILMN NewILLUMINA INC$18,500,00050,000
+100.0%
0.63%
TMO BuyTHERMO FISHER SCIENTIFIC INC$18,165,000
+157.1%
39,000
+143.8%
0.62%
+141.4%
BSX NewBOSTON SCIENTIFIC CORP$17,975,000500,000
+100.0%
0.61%
POST NewPOST HLDGS INC$17,778,000176,000
+100.0%
0.60%
VTRS NewVIATRIS INC$17,541,000936,000
+100.0%
0.60%
EGRX SellEAGLE PHARMACEUTICALS INC$16,951,000
-40.6%
364,000
-45.8%
0.58%
-44.3%
AMZN SellAMAZON COM INC$16,610,000
-46.8%
5,100
-48.6%
0.56%
-50.1%
ASMB BuyASSEMBLY BIOSCIENCES INC$15,875,000
+25.7%
2,624,000
+241.7%
0.54%
+17.9%
AVTR SellAVANTOR INC$15,426,000
+12.1%
548,000
-10.5%
0.52%
+5.2%
KHC SellKRAFT HEINZ CO$13,864,000
-53.7%
400,000
-60.0%
0.47%
-56.5%
MSFT BuyMICROSOFT CORP$12,900,000
+91.7%
58,000
+81.2%
0.44%
+79.9%
AXNX BuyAXONICS MODULATION TECHNOLOG$12,380,000
+73.2%
248,000
+77.1%
0.42%
+62.5%
CLX NewCLOROX CO DEL$12,115,00060,000
+100.0%
0.41%
PG NewPROCTER AND GAMBLE CO$12,105,00087,000
+100.0%
0.41%
FREE BuyWHOLE EARTH BRANDS INC$12,077,000
+75.7%
1,108,000
+34.5%
0.41%
+65.1%
ADMS  ADAMAS PHARMACEUTICALS INC$11,873,000
+5.1%
2,742,0000.0%0.40%
-1.5%
EPC SellEDGEWELL PERS CARE CO$11,619,000
-61.3%
336,000
-68.8%
0.40%
-63.8%
NTRA NewNATERA INC$11,544,000116,000
+100.0%
0.39%
LIVN BuyLIVANOVA PLC$11,388,000
+403.7%
172,000
+244.0%
0.39%
+372.0%
CRSP SellCRISPR THERAPEUTICS AGnamen akt$11,024,000
-35.4%
72,000
-64.7%
0.38%
-39.4%
CLVS BuyCLOVIS ONCOLOGY INC$10,829,000
+0.5%
2,256,000
+22.1%
0.37%
-5.9%
SIBN BuySI BONE INC$9,688,000
+59.6%
324,000
+26.6%
0.33%
+50.0%
UBER BuyUBER TECHNOLOGIES INC$9,180,000
+67.8%
180,000
+20.0%
0.31%
+56.8%
EYEG  EYEGATE PHARMACEUTICALS INC$8,950,000
+25.8%
1,815,5000.0%0.30%
+17.8%
AYTU NewAYTU BIOSCIENCE INC$7,973,0001,333,334
+100.0%
0.27%
WDAY NewWORKDAY INCcl a$7,188,00030,000
+100.0%
0.24%
AVNS SellAVANOS MED INC$7,157,000
+9.4%
156,000
-20.8%
0.24%
+2.5%
PRTS NewCARPARTS COM INC$6,815,000550,000
+100.0%
0.23%
WYNN SellWYNN RESORTS LTD$6,770,000
+12.2%
60,000
-28.6%
0.23%
+5.0%
NEPT NewNEPTUNE WELLNESS SOLUTIONS I$6,500,0004,166,666
+100.0%
0.22%
PLAN SellANAPLAN INC$6,035,000
+9.6%
84,000
-4.5%
0.20%
+2.5%
ADBE NewADOBE SYSTEMS INCORPORATED$6,001,00012,000
+100.0%
0.20%
DT NewDYNATRACE INC$5,885,000136,000
+100.0%
0.20%
SMAR SellSMARTSHEET INC$5,682,000
+15.0%
82,000
-18.0%
0.19%
+7.8%
CRWD NewCROWDSTRIKE HLDGS INCcl a$5,296,00025,000
+100.0%
0.18%
SELB NewSELECTA BIOSCIENCES INC$4,957,0001,636,000
+100.0%
0.17%
CRI NewCARTERS INC$4,930,00052,404
+100.0%
0.17%
VFC NewV F CORP$4,252,00049,781
+100.0%
0.14%
RZLT NewREZOLUTE INC$4,005,000333,990
+100.0%
0.14%
TELA BuyTELA BIO INC$3,850,000
+45.5%
256,000
+60.0%
0.13%
+36.5%
 TENAX THERAPEUTICS INC$3,757,000
+20.8%
2,019,9950.0%0.13%
+13.3%
BXRX NewBAUDAX BIO INC$3,538,0003,503,351
+100.0%
0.12%
AMYT SellAMRYT PHARMA PLCsponsored ads$2,832,000
-25.1%
200,000
-34.6%
0.10%
-29.9%
LMNL NewLIMINAL BIOSCIENCES INC$2,374,000565,242
+100.0%
0.08%
RWLK NewREWALK ROBOTICS LTD$1,841,0001,394,944
+100.0%
0.06%
BuyOBALON THERAPEUTICS INC$1,650,000
+144.8%
1,100,000
+48.6%
0.06%
+133.3%
SYTAW  SIYATA MOBILE INC*w exp 09/24/202$1,268,000
+161.4%
150,0000.0%0.04%
+138.9%
NERV  MINERVA NEUROSCIENCES INC$1,170,000
-26.4%
500,0000.0%0.04%
-31.0%
PTE NewPOLARITYTE INC$1,149,0001,689,220
+100.0%
0.04%
CBLI NewCLEVELAND BIOLABS INC$1,104,000320,053
+100.0%
0.04%
KBNTW  KUBIENT INC*w exp 07/09/202$1,108,000
+201.9%
275,0000.0%0.04%
+192.3%
MDGSW  MEDIGUS LTD*w exp 07/23/202$1,095,000
+72.7%
1,285,7150.0%0.04%
+60.9%
SRGA NewSURGALIGN HOLDINGS INC$955,000436,000
+100.0%
0.03%
GOVXW  GEOVAX LABS INC*w exp 09/29/202$887,000
+5.0%
391,7000.0%0.03%
-3.2%
VXRT  VAXART INC$831,000
-14.2%
145,5230.0%0.03%
-20.0%
TMDI NewTITAN MED INC$477,000278,787
+100.0%
0.02%
CYTH NewCYCLO THERAPEUTICS INC$435,000100,000
+100.0%
0.02%
MOTS SellMOTUS GI HLDGS INC$329,000
-88.3%
347,221
-87.9%
0.01%
-89.2%
CYTHW NewCYCLO THERAPEUTICS INC*w exp 11/14/202$156,00050,000
+100.0%
0.01%
GOVX ExitGEOVAX LABS INC$0-50,464
-100.0%
-0.01%
NMRD ExitNEMAURA MED INC$0-88,830
-100.0%
-0.01%
CLRO ExitCLEARONE INC$0-350,000
-100.0%
-0.03%
ATRS ExitANTARES PHARMA INC$0-428,000
-100.0%
-0.04%
ONCT ExitONCTERNAL THERAPEUTICS INC$0-1,316,163
-100.0%
-0.08%
PRFX ExitPAINREFORM LTD$0-638,961
-100.0%
-0.11%
PROG ExitPROGENITY INC$0-400,000
-100.0%
-0.13%
MNKKQ ExitMALLINCKRODT PUB LTD COcall$0-40,000
-100.0%
-0.14%
EXAS ExitEXACT SCIENCES CORP$0-40,000
-100.0%
-0.15%
UAA ExitUNDER ARMOUR INCcl a$0-530,108
-100.0%
-0.22%
CFMS ExitCONFORMIS INC$0-7,477,385
-100.0%
-0.23%
ETTX ExitENTASIS THERAPEUTICS HLDGS I$0-3,510,981
-100.0%
-0.26%
AUPH ExitAURINIA PHARMACEUTICALS INC$0-500,000
-100.0%
-0.27%
GPS ExitGAP INC$0-500,000
-100.0%
-0.31%
OBSV ExitOBSEVA SA$0-4,338,927
-100.0%
-0.39%
AVYA ExitAVAYA HLDGS CORP$0-736,000
-100.0%
-0.41%
GNMK ExitGENMARK DIAGNOSTICS INC$0-792,000
-100.0%
-0.41%
HRC ExitHILL ROM HLDGS INC$0-164,000
-100.0%
-0.50%
JACK ExitJACK IN THE BOX INC$0-175,438
-100.0%
-0.50%
MYL ExitMYLAN NV$0-1,128,000
-100.0%
-0.61%
DECK ExitDECKERS OUTDOOR CORP$0-79,755
-100.0%
-0.64%
ALT ExitALTIMMUNE INC$0-1,436,000
-100.0%
-0.69%
DLTR ExitDOLLAR TREE INC$0-220,747
-100.0%
-0.73%
CL ExitCOLGATE PALMOLIVE CO$0-300,000
-100.0%
-0.84%
CVS ExitCVS HEALTH CORP$0-500,000
-100.0%
-1.06%
LOW ExitLOWES COS INC$0-206,340
-100.0%
-1.24%
AMAG ExitAMAG PHARMACEUTICALS INC$0-4,120,000
-100.0%
-1.40%
WSM ExitWILLIAMS SONOMA INC$0-445,000
-100.0%
-1.46%
MRK ExitMERCK & CO. INC$0-524,000
-100.0%
-1.58%
ALXN ExitALEXION PHARMACEUTICALS INC$0-500,000
-100.0%
-2.08%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-16
  • View 13F-HR/A filed 2021-03-04
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ENANTA PHARMACEUTICALS INC30Q3 20232.7%
SPDR S&P 500 ETF TR28Q3 202329.5%
MADRIGAL PHARMACEUTICALS INC27Q3 20232.9%
VANDA PHARMACEUTICALS INC26Q3 20219.4%
REGENERON PHARMACEUTICALS25Q3 20233.2%
ENERGIZER HLDGS INC NEW22Q2 20233.7%
ANTARES PHARMA INC21Q3 20206.6%
INCYTE CORP21Q3 20232.8%
VOYAGER THERAPEUTICS INC21Q3 20232.0%
BLUEBIRD BIO INC20Q4 20211.8%

View ARMISTICE CAPITAL, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
ARMISTICE CAPITAL, LLC Q4 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Avalo Therapeutics, Inc.June 28, 2023588,8504.7%
Addex Therapeutics Ltd.February 16, 2023675,2955.0%
Arcadia Biosciences, Inc.February 14, 20232,675,40910.0%
Avinger IncFebruary 14, 2023789,40010.0%
Baudax Bio, Inc.February 14, 20231,165,7095.0%
BIORA THERAPEUTICS, INC.February 14, 202312,989,6485.7%
Bit Digital, IncFebruary 14, 20233,161,8893.7%
Bruush Oral Care Inc.February 14, 20231,122,92210.0%
CATALYST PHARMACEUTICALS, INC.Sold outFebruary 14, 202300.0%
Clarus Therapeutics Holdings, Inc.February 14, 20232,732,1695.0%

View ARMISTICE CAPITAL, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View ARMISTICE CAPITAL, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been amended

Export ARMISTICE CAPITAL, LLC's holdings